Comment on: Wieser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647

Anita Feller; Matthias Bopp; Matthias Lorez; Ulrich Zellweger; Martin Adam; Ivan Curjuric; Katharina Staehelin; Aurel Perren; Yvan Bergeron; Elisabetta Rapiti; Mohsen Mousavi; Joachim Diebold; Daniela Dyntar; Jean-Luc Bulliard; Manuela Maspoli Conconi; Andrea Bordoni; Isabelle Konzelmann; Ulrich Wagner; Sabine Rohrmann

doi:10.4414/smw.2020.20179

Technical comment

Vol. 150 No. 0506 (2020)

Comment on: Wieser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647

Anita Feller
Matthias Bopp
Matthias Lorez
Ulrich Zellweger
Martin Adam
Ivan Curjuric
Katharina Staehelin
Aurel Perren
Yvan Bergeron
Elisabetta Rapiti
Mohsen Mousavi
Joachim Diebold
Daniela Dyntar
Jean-Luc Bulliard
Manuela Maspoli Conconi
Andrea Bordoni
Isabelle Konzelmann
Ulrich Wagner
Sabine Rohrmann

DOI: https://doi.org/10.4414/smw.2020.20179
Cite this as:: Swiss Med Wkly. 2020;150:w20179
Published: 07.02.2020

References

Wieser S, Schmidt M, Kind AB, Heinzelmann-Schwarz VA. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly. 2018;148:w14647. doi:.https://doi.org/10.4414/smw.2018.14647
dos Santos Silva I. Cancer epidemiology: principles and methods. Lyon, France: International Agency for Research on Cancer (IARC); 1999.
Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer. 2015;137(9):2060–71. doi:.https://doi.org/10.1002/ijc.29670
Arndt V. Population-based cancer registration and research in Switzerland: examples, limitations and perspectives. Swiss Cancer Bulletin. 2016;36(2):163–7.
Clough-Gorr K, Bosshard D, Heusser R, Noseda G. The Potential Beneﬁ ts for Cancer Prevention and Control in Switzerland from a New National Cancer Registration Law. Swiss Cancer Bulletin. 2011;31(2):154–5.
Maier B, Wagner K, Behrens S, Bruch L, Busse R, Schmidt D, et al. Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage. BMC Health Serv Res. 2016;16(1):605. doi:.https://doi.org/10.1186/s12913-016-1840-5
Thommen D, Weissenberger N, Schuetz P, Mueller B, Reemts C, Holler T, et al. Head-to-head comparison of length of stay, patients’ outcome and satisfaction in Switzerland before and after SwissDRG-Implementation in 2012 in 2012: an observational study in two tertiary university centers. Swiss Med Wkly. 2014;144:w13972. doi:.https://doi.org/10.4414/smw.2014.13972
Middleton RJ, Gavin AT, Reid JS, O’Reilly D. Accuracy of hospital discharge data for cancer registration and epidemiological research in Northern Ireland. Cancer Causes Control. 2000;11(10):899–905. doi:.https://doi.org/10.1023/A:1026543100223
Lorez M, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Dehler S, et al. Evaluation of completeness of case ascertainment in Swiss cancer registration. Eur J Cancer Prev. 2017;26:S139–46. doi:.https://doi.org/10.1097/CEJ.0000000000000380
Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P, et al. Systematic review of discharge coding accuracy. J Public Health (Oxf). 2012;34(1):138–48. doi:.https://doi.org/10.1093/pubmed/fdr054

Publication image

How to Cite

1.

Feller A, Bopp M, Lorez M, Zellweger U, Adam M, Curjuric I, Staehelin K, Perren A, Bergeron Y, Rapiti E, Mousavi M, Diebold J, Dyntar D, Bulliard J-L, Maspoli Conconi M, Bordoni A, Konzelmann I, Wagner U, Rohrmann S. Comment on: Wieser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647. Swiss Med Wkly [Internet]. 2020 Feb. 7 [cited 2024 Nov. 23];150(0506):w20179. Available from: https://smw.ch/index.php/smw/article/view/2731

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Mirjam Gross-Erne, Lukas Zimmerli, Stefano Bassetti, Qiyu Li, Anita Feller, Walter Mingrone, A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines , Swiss Medical Weekly: Vol. 153 No. 7 (2023)
Christina Hempel-Bruder, Lamprini Syrogiannouli, Rémi Schneider, Sarah Bissig, Oliver Senn, Kali Tal, Jean-Luc Bulliard, Cyril Ducros, Christian P. R. Schmid, Reto Auer, Kevin Selby, Colorectal cancer testing rates after implementation of an organised screening programme in Vaud, Switzerland , Swiss Medical Weekly: Vol. 153 No. 4 (2023)
Magdalena Mueller, Monika Huembelin, Ciril Baechli, Ulrich Wagner, Philipp Schuetz, Beat Mueller, Alexander Kutz, Association of in-hospital multimorbidity with healthcare outcomes in Swiss medical inpatients , Swiss Medical Weekly: Vol. 151 No. 0506 (2021)
Diana Walther, Ivan Curjuric, Julia Dratva, Emmanuel Schaffner, Carlos Quinto, Thierry Rochat, Jean-Michel Gaspoz, Luc Burdet, Pierre-Olivier Bridevaux, Marco Pons, Margaret W. Gerbase, Christian Schindler, Nicole Probst-Hensch, High blood pressure: prevalence and adherence to guidelines in a population-based cohort , Swiss Medical Weekly: Vol. 146 No. 2728 (2016)
Nicole Steck, Christoph Junker, Matthias Bopp, Matthias Egger, Marcel Zwahlen, Time trend of suicide in Swiss male farmers and comparison with other men: a cohort study , Swiss Medical Weekly: Vol. 150 No. 2122 (2020)
Simon Wirth, Maria-Eleni Syleouni, Nena Karavasiloglou, Sabina Rinaldi, Dimitri Korol, Miriam Wanner, Sabine Rohrmann, Incidence and mortality trends of thyroid cancer from 1980 to 2016 , Swiss Medical Weekly: Vol. 151 No. 4344 (2021)
Cédric Poyet, Thomas Paul Scherer, Mirjam Kunz, Miriam Wanner, Dimitri Korol, Gianluca Rizzi, Basil Kaufmann, Sabine Rohrmann, Thomas Hermanns, Retrospective analysis of the uptake of active surveillance for low-risk prostate cancer in Zurich, Switzerland , Swiss Medical Weekly: Vol. 153 No. 7 (2023)
Sandro T. Stoffel, Roger von Moos, Beat Thürlimann, Richard Cathomas, Silke Gillessen, Ursina Zürrer-Härdi, Thomas von Briel, Sandro Anchisi, Anita Feller, Corinne Schär, Daniel Dietrich, Matthias Schwenkglenks, Judith E. Lupatsch, Michael Mark, Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland – the SAKK 95/16 prostate study , Swiss Medical Weekly: Vol. 151 No. 0910 (2021)
Valentina Allmann, Daniela Dyntar, Dirk Lehnick, Marco Dressler, Kristin Zeidler, Philipp Niederberger, Jeanne Godau, Joachim Diebold, Oliver Gautschi, Overall survival and role of programmed death ligand 1 expression in patients with metastatic non-small-cell lung cancer and immunotherapy: an observational study from central Switzerland , Swiss Medical Weekly: Vol. 153 No. 1 (2023)
Nadine Häusler, Matthias Bopp, Oliver Hämmig, Informal caregiving, work-privacy conflict and burnout among health professionals in Switzerland – a cross-sectional study , Swiss Medical Weekly: Vol. 147 No. 4546 (2017)

1 2 3 4 > >>

[1] Wieser S, Schmidt M, Kind AB, Heinzelmann-Schwarz VA. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly. 2018;148:w14647. doi:.https://doi.org/10.4414/smw.2018.14647

[2] dos Santos Silva I. Cancer epidemiology: principles and methods. Lyon, France: International Agency for Research on Cancer (IARC); 1999.

[3] Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer. 2015;137(9):2060–71. doi:.https://doi.org/10.1002/ijc.29670

[4] Arndt V. Population-based cancer registration and research in Switzerland: examples, limitations and perspectives. Swiss Cancer Bulletin. 2016;36(2):163–7.

[5] Clough-Gorr K, Bosshard D, Heusser R, Noseda G. The Potential Beneﬁ ts for Cancer Prevention and Control in Switzerland from a New National Cancer Registration Law. Swiss Cancer Bulletin. 2011;31(2):154–5.

[6] Maier B, Wagner K, Behrens S, Bruch L, Busse R, Schmidt D, et al. Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage. BMC Health Serv Res. 2016;16(1):605. doi:.https://doi.org/10.1186/s12913-016-1840-5

[7] Thommen D, Weissenberger N, Schuetz P, Mueller B, Reemts C, Holler T, et al. Head-to-head comparison of length of stay, patients’ outcome and satisfaction in Switzerland before and after SwissDRG-Implementation in 2012 in 2012: an observational study in two tertiary university centers. Swiss Med Wkly. 2014;144:w13972. doi:.https://doi.org/10.4414/smw.2014.13972

[8] Middleton RJ, Gavin AT, Reid JS, O’Reilly D. Accuracy of hospital discharge data for cancer registration and epidemiological research in Northern Ireland. Cancer Causes Control. 2000;11(10):899–905. doi:.https://doi.org/10.1023/A:1026543100223

[9] Lorez M, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Dehler S, et al. Evaluation of completeness of case ascertainment in Swiss cancer registration. Eur J Cancer Prev. 2017;26:S139–46. doi:.https://doi.org/10.1097/CEJ.0000000000000380

[10] Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P, et al. Systematic review of discharge coding accuracy. J Public Health (Oxf). 2012;34(1):138–48. doi:.https://doi.org/10.1093/pubmed/fdr054